Latest Venous thrombosis Stories
The National Blood Clot Alliance will continue its long-standing collaboration with the Centers for Disease Control and Prevention (CDC), as it has been awarded another five-year CDC Cooperative Agreement
The Firm is evaluating potential legal claims on behalf of individuals who allegedly suffered uncontrollable internal bleeding and other serious side effects due to the use of the blood thinning
MarketOptimizer.org adds “Venous (Vein) Thrombosis Global Clinical Trials Review, H2, 2014” to its store.
World Thrombosis Day launches to bring awareness to largely preventable disease as comprehensive science review and public survey reveal large gap in public's knowledge CHAPEL HILL, N.C., Oct.
The Firm is evaluating Xarelto lawsuits on behalf of individuals who suffered life-threatening internal bleeding, deep vein thrombosis, pulmonary embolism, and other serious complications, allegedly
The Firm is evaluating potential legal claims on behalf of Xarelto patients who suffered uncontrollable internal bleeding and other complications, allegedly due to their use of the blood thinner.
The Firm is evaluating Xarelto lawsuits on behalf of individuals who suffered life-threatening internal bleeding, stroke, deep vein thrombosis, pulmonary embolism, or other serious injuries allegedly
Provides Another Important and Highly Complex Injectable to Complement Mylan Institutional's Growing Portfolio in the U.S. PITTSBURGH, Sept. 10, 2014 /PRNewswire/ -- Mylan Inc.
Aspirin may be a promising alternative for those who can’t take long-term anticoagulant drugs that prevent clots from reoccurring in the veins
- Sleep; the state or condition of being asleep.